Explore Watchlists Pricing

ALNYLAM PHARMACEUTICALS, INC. (ALNY) Balance sheet

Market cap

$40.5B

P/E ratio

131.1x

Summary Financials

Income statement Balance sheet Cash flow Other

	2010/12	2011/12	2012/12	2013/12	2014/12	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12	2025/12
Cash and cash equivalents	75	70	51	53	75	181	194	645	420	547	497	820	866	815	969	1,659
Total cash & short-term investments	75	70	51	53	75	181	194	645	420	547	497	820	866	815	969	1,659
Accounts receivable, net	-	-	-	-	-	-	-	-	19	43	102	199	238	328	405	778
Inventories	-	-	-	-	-	-	-	-	24	56	75	86	129	89	79	83
Total current assets	254	152	125	254	746	1,105	672	1,765	1,201	1,716	2,615	2,809	2,692	2,983	3,295	4,051
Property, plant and equipment, net	18	15	20	16	22	28	115	182	321	425	465	502	523	526	503	513
Marketable securities, non-current	117	114	103	105	280	252	325	14	-	-	-	-	-	-	-	-
Total assets	393	282	288	421	1,080	1,387	1,263	1,995	1,575	2,395	3,407	3,643	3,546	3,830	4,240	4,966
Accounts payable	9	6	4	6	15	17	54	28	60	50	52	73	98	56	88	116
Total current liabilities	102	81	48	54	95	62	132	144	179	353	585	696	768	968	1,186	1,466
Total liabilities	235	164	153	150	143	122	343	228	273	956	2,391	3,055	3,705	4,051	4,173	4,177
Retained earnings	-343	-401	-507	-596	-957	-1,247	-1,657	-2,148	-2,841	-3,727	-4,585	-5,438	-6,569	-7,010	-7,288	-6,703
Stockholders' equity	158	118	134	270	936	1,265	920	1,766	1,302	1,439	1,016	588	-158	-221	67	789
Working capital	-	-	-	-	-	-	-	-